Table 2.
Primary and secondary outcomes
| Outcomes | Dialysate K 2 mmol/l (total = 695 sessions) | Dialysate K 3 mmol/l (total = 685 sessions) | P |
|---|---|---|---|
| Primary outcome | |||
| Proportion of dialysis session with intradialytic hypertensiona | 380 (54.7) | 364 (53.1) | 0.788b |
| Secondary outcome | |||
| Proportion of dialysis session with that had intradialytic systolic blood pressure increased >20 mm Hg | 231 (33.2) | 217 (31.7) | 0.932b |
| Average intradialytic systolic blood pressure (mm Hg) | 140.7 ± 12.2 | 143.7 ± 13.4 | Treatment effect: P = 0.001 Sequence effect: P = 0.458 Period effect: P = 0.445 Carryover effect: P = 0.058 |
| Average intradialytic mean arterial pressure (mm Hg) | 99.0 ± 11.4 | 100.9 ± 11.8 | Treatment effect: P = 0.011 Sequence effect: P = 0.236 Period effect: P = 0.557 Carryover effect: P = 0.044 |
Intradialytic hypertension was defined as an increase in intradialytic systolic blood pressure of more than 10 mm Hg. Data were presented in mean ± SD or n (%).
P values were calculated by mixed-effects logistic regression.